Adults with Down syndrome (DS) are predisposed to Alzheimer’s disease (AD) and a characterization of glucose metabolism change throughout AD progression has yet to be performed in this population. Using FDG PET, regional glucose metabolism was evaluated across groups of cognitively stable DS (CS-DS), DS with mild cognitive impairment or Alzheimer’s disease (MCI-DS/AD), and healthy non-DS sibling controls.
Down Syndome
Live Stream/Online Only – Day with the Experts: Down Syndrome 2020
Live Stream/Online Only Learn about advances in research and clinical services. Hosted in partnership with the Madison Area Down Syndrome Society and GiGi’s Playhouse Sponsored by the Friends of the Waisman Center To learn more about …